TREATMENT FOR HEPATITIS C

Summary

That this House is concerned to note that more than 600, 000 people in the United Kingdom are infected with hepatitis C; notes that many of these were infected as a result of blood products treatment by the National Health Service; welcomes the success of Ribavirin and Recombinant Interferon Alpha trials in fighting hepatitis C; regrets that some health authorities, including Avon Health Authority, refuse to fund the use of these new treatments; is concerned that as a result of this treatment by postcode, many patients, such as Mrs Patricia Greed of Weston-super-Mare, do not receive necessary medical care; and calls on health authorities and the Department of Health to ensure that all hepatitis C sufferers, regardless of where they live, have equal access to treatment.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 21 March 2000

   Early Day Motion

   That this House is concerned to note that more than 600, 000 people in the United Kingdom are infected with hepatitis C; notes that many of these were infected as a result of blood products treatment by the National Health Service; welcomes the success of Ribavirin and Recombinant Interferon Alpha trials in fighting hepatitis C; regrets that some health authorities, including Avon Health Authority, refuse to fund the use of these new treatments; is concerned that as a result of this treatment by postcode, many patients, such as Mrs Patricia Greed of Weston-super-Mare, do not receive necessary medical care; and calls on health authorities and the Department of Health to ensure that all hepatitis C sufferers, regardless of where they live, have equal access to treatment.

   Source: Early Day Motion

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• Lord Cotter · Liberal Democrat · Primary sponsor

Related records

No cross-record relationships stored yet.